Education
- Fellowship in Hematology, Oncology
University of Kentucky, Lexington, KY
- Internship and Residency in Internal Medicine
University of Iowa Hospitals and Clinics, Iowa City, IA
- Doctor of Medicine
University of Louisville, Louisville, KY
- Bachelor of the Arts in Biology
University of Louisville, Louisville, KY
Research Interest
She has a special interest in cancers of the gastrointestinal tract as well as clinical research within oncology. She also participates in and advocates for clinical cancer research within community oncology practices.
Other Information
In her spare time, Dr. Cline enjoys reading, being outdoors, exercise for body and mind, spending time with her family, and trying to hone a greener thumb in her garden.
Publications
-
Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL
Blood, 2017
-
Brentuximab Vedotin in Combination With Dacarbazine or Bendamustine for Frontline Treatment of Hodgkin Lymphoma in Patients Aged 60 Years and Above: Interim Results of a Multicohort Phase II Study
57th Annual ASH Annual Meeting, 2015
-
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Relapsed or Metastatic Head and Neck Squamous Cell Cancer
Annals of Oncology, 2015
-
SPIRITT (Study 20060141): A Randomized Phase II Study of FOLFIRI With Either Panitumumab (Pmab) or Bevacizumab (Bev) As Second-Line Treatment (TX) in Patients (Pts) With Wild-Type (WT) KRAS Metastatic Colorectal Cancer (mCRC)
ASCO University, 2013
-
Paclitaxel, Gemcitabine, Irradiation, and R115777 for Pancreas Cancer
OncoTargets and Therapy, 2013
Show less publications